Unveiling Emerging Avenues in Antiviral Research: Navigating Clinical Trials and Regulatory Landscapes
Author:
Publisher
Springer Nature Singapore
Link
https://link.springer.com/content/pdf/10.1007/978-981-99-9195-2_17
Reference170 articles.
1. Al-Harrasi A, Behl T, Upadhyay T et al (2022) Targeting natural products against SARS-CoV-2. Environ Sci Pollut Res Int 29:42404–42432. https://doi.org/10.1007/s11356-022-19770-2
2. Ameeduzzafar ISS, Abbas Bukhari SN et al (2018) Formulation and optimization of levofloxacin loaded chitosan nanoparticle for ocular delivery: in-vitro characterization, ocular tolerance and antibacterial activity. Int J Biol Macromol 108:650–659. https://doi.org/10.1016/j.ijbiomac.2017.11.170
3. Andrade BS, Rangel F de S, Santos NO et al (2020) Repurposing approved drugs for guiding COVID-19 prophylaxis: a systematic review. Front Pharmacol 11:590598. https://doi.org/10.3389/fphar.2020.590598
4. Angus DC, Berry S, Lewis RJ et al (2020) The REMAP-CAP (randomized embedded multifactorial adaptive platform for community-acquired pneumonia) study. Rationale and design. Ann Am Thorac Soc 17:879–891
5. Arabi YM, Al Dorzi HM, Aldekhyl S et al (2023) Long term outcomes of patients with COVID 19 treated with helmet noninvasive ventilation or usual respiratory support: follow up study of the Helmet COVID randomized clinical trial. Intensive Care Med 49:302–312
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3